References
- Beresford, G. W. and Boss, J. M. (2001) CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat. Immunol. 2, 652−657 https://doi.org/10.1038/89810
- Chambers, A. E., Banerjee, S., Chaplin, T., Dunne, J., Debernardi, S., et al. (2003) Histone acetylation-mediated regulation of genes in leukaemic cells. Eur. J. Cancer 39, 1165− 1175 https://doi.org/10.1016/S0959-8049(03)00072-8
- Chang, H. M., Paulson, M., Holko, M., Rice, C. M., Williams, B. R., et al. (2004) Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc. Natl. Acad. Sci. USA 101, 9578−9583
- de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S., and van Kuilenburg, A. B. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737−749 https://doi.org/10.1042/BJ20021321
- Ehrenhofer-Murray, A. E. (2004) Chromatin dynamics at DNA replication, transcription and repair. Eur. J. Biochem. 271, 2335−2349 https://doi.org/10.1111/j.1432-1033.2004.04162.x
- Gray, S. G. and Ekstrom, T. J. (2001) The human histone deacetylase family. Exp. Cell. Res. 262, 75−83
- Jinquan, T., Jing, C., and Jacobi, H. H. (2000) CXCR3 expression and activation of eosinophils: role of IFN-gammainducible protein-10 and monokine induced by IFN-gamma. J. Immunol. 165, 1548−1556
- Kristeleit, R., Fong, P., Aherne, G. W., and de Bono, J. (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clin. Lung Cancer 7 (Suppl. 1), S19−30 https://doi.org/10.3816/CLC.2005.s.004
- Majumder, S., Zhou, L. Z., Chaturvedi, P., Babcock, G., Aras, S., et al. (1998) p48/ STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha. J. Immunol. 161, 4736−4744
- Nazar, A. S., Cheng, G., Shin, H. S., Brothers, P. N., Dhib-Jalbut, S., et al. (1997) Induction of IP-10 chemokine promoter by measles virus: comparison with interferon-gamma shows the use of the same response element but with differential DNAprotein binding profiles. J. Neuroimmunol. 77, 116−127 https://doi.org/10.1016/S0165-5728(97)00070-2
- Nusinzon, I. and Horvath, C. M. (2003) Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. USA 100, 14742−14747
- Platanias, L. C. (2005) Mechanisms of type-I- and type-IIinterferon- mediated signalling. Nat. Rev. Immunol. 5, 375− 386 https://doi.org/10.1038/nri1604
- Puppin, C., D'Aurizio, F., D'Elia, A. V., Cesaratto, L., Tell, G., et al. (2005) Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors. Endocrinology 146, 3967−3974 https://doi.org/10.1210/en.2005-0128
- Schroder, K., Hertzog, P. J., Ravasi, T., and Hume, D. A. (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163−189 https://doi.org/10.1189/jlb.0603252
- Somech, R., Izraeli, S. J., and Simon, A. (2004) Histone deacetylase inhibitors--a new tool to treat cancer. Cancer Treat. Rev. 30, 461−472 https://doi.org/10.1016/j.ctrv.2004.04.006
- Strahl, B. D. and Allis, C. D. (2000) The language of covalent histone modifications. Nature 403, 41-45 https://doi.org/10.1038/47412